Intelligence Platform
Patents
Browse 166 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8541182
Biological marker for inflammation
granted patentUS 8529872
Seeds and markers for use in imaging
granted patentUS 8436224
Methods for testing for caloric restriction (CR) mimetics
granted patentUS 8403844
Methods for interventions
granted patentUS 8241862
Perinucleolar compartment as a cancer marker
granted patentUS 8198254
Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer
granted patentUS 8183009
Assaying cellular markers for the evaluation of tumors
granted patentUS 8173602
Detecting CYP24 expression level as a marker for predisposition to cancer
granted patentUS 8163509
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 rece
granted patentUS 8076099
Biomarkers of Francisella infection
granted patentUS 8030010
Method for detecting a biomarker of oxidative stress in a biological sample
granted patentUS 8030012
Id-1 and Id-2 genes and products as markers of epithelial cancer
granted patentUS 7981610
ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphom
granted patentUS 7960605
Methods for testing for caloric restriction (CR) mimetics
granted patentUS 7955602
Annexin proteins and autoantibodies as serum markers for cancer
granted patentUS 7897340
Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker
granted patentUS 7879548
Detection of biomarkers for neuropsychiatric disorders
granted patentUS 7825159
Mixtures of aromatic esters for marking or tagging organic products, marker compositions c
granted patentUS 7807393
Biomarkers for prostate cancer
granted patentUS 7776593
Hes6 as a marker of pancreatic endocrine cells
granted patentUS 7759081
Annexin proteins and autoantibodies as serum markers for cancer
granted patentUS 7670599
YKL-40 as a marker and prognostic indicator for cancers
granted patentUS 7648826
Detecting CYP24 expression level as a marker for predisposition to cancer
granted patentUS 7442558
Phthalamide-lanthanide complexes for use as luminescent markers
granted